Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study.
| Autor: | Zubrzycka-Sienkiewicz, Anna, Klama, Kamilla, Ullmann, Martin, Petit-Frere, Corinne, Baker, Peter, Monnet, Joëlle, Illes, Andras |
|---|---|
| Zdroj: | RMD Open; Jan2024, Vol. 10 Issue 1, p1-15, 15p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|